Discover hundreds of clinical trials in Phoenix.
Search clinical trials in Phoenix by condition or phase.
With several prominent research institutions and a robust healthcare network, Phoenix stands out as a significant hub for clinical trials. The city hosts leading medical centers such as the Mayo Clinic’s Scottsdale campus, the Translational Genomics Research Institute (TGen), and the Arizona State University (ASU) Biomedical Engineering department. These institutions are at the forefront of advancing clinical research and innovation. The diverse population of Phoenix provides a broad participant base too, enhancing the accuracy and relevance of clinical studies.
Phoenix offers distinctive advantages for those volunteering in clinical trials. The city's diverse and growing population provides a rich pool of participants, which enhances the accuracy and applicability of research outcomes.
Choosing to participate in a clinical trial in Phoenix allows individuals to contribute to critical medical advancements while benefiting from a supportive and well-established clinical research environment. The city's combination of a diverse participant base and cutting-edge research facilities makes it an ideal location for advancing medical science and improving healthcare outcomes.
Phoenix is known for its robust clinical research landscape, addressing a wide range of medical conditions and diseases through innovative trials.
Phoenix has become a prominent center for cancer research, leveraging institutions like the Mayo Clinic Scottsdale and the Translational Genomics Research Institute (TGen). Trials here often explore groundbreaking cancer treatments such as immunotherapy, which harnesses the body’s immune system to target cancer cells, and targeted therapies that specifically attack cancerous cells while sparing healthy ones.
Researchers in Phoenix are also investigating novel drug combinations and personalized medicine approaches to improve outcomes for patients with various cancers, including breast, prostate, and lung cancers.
The city’s research efforts in cardiovascular health focus on conditions such as coronary artery disease, heart failure, and hypertension. Cardiovascular clinical trials in Phoenix evaluate new medications that aim to better manage high blood pressure and cholesterol levels, as well as innovative surgical techniques like minimally invasive valve replacements.
Studies also explore lifestyle interventions and preventive strategies such as weight management treatments to reduce the risk of cardiovascular events and improve overall heart health.
Phoenix is actively involved in researching neurological diseases, with a particular emphasis on Alzheimer's disease, Parkinson's disease, and multiple sclerosis (MS). Neurology trials often investigate potential disease-modifying drugs that could slow or halt disease progression, as well as new diagnostic tools that might improve early detection.
Research in this area also includes exploring advanced imaging techniques and cognitive therapies to enhance patient care and quality of life.
Clinical trials in Phoenix are at the forefront of research into diabetes and other endocrine disorders. Studies often focus on developing new insulin formulations and glucose monitoring technologies to better manage Type 1 and Type 2 diabetes. Clinical research here also explores treatments for thyroid disorders and adrenal gland diseases, aiming to improve hormone regulation and overall metabolic health.
Phoenix's trials in respiratory diseases address chronic conditions like asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Research includes evaluating new inhalation devices and drug delivery systems that provide more effective symptom relief.
Trials in Phoenix also focus on innovative therapies that could potentially alter the disease course, such as biologics that target specific inflammatory pathways or novel drug combinations to manage chronic symptoms.
Researchers in Phoenix are engaged in trials for autoimmune conditions including rheumatoid arthritis, lupus, and multiple sclerosis (MS). These studies often investigate new immunomodulatory drugs that aim to reduce inflammation and prevent joint damage. Research also explores potential treatments that could more effectively manage symptoms and improve functional outcomes for individuals living with these chronic diseases.
Phoenix’s clinical trials also address a range of infectious diseases, such as HIV/AIDS, hepatitis, and emerging viral infections like COVID-19. Trials often focus on developing new antiviral drugs, vaccines, and treatment protocols to enhance disease management and prevention.
Research in this area is crucial for addressing both ongoing and emerging infectious threats, improving patient outcomes and public health responses.
In Phoenix, clinical trials are governed by both federal and state regulations to ensure safety, ethical standards, and scientific validity. At the federal level, trials must comply with guidelines established by the U.S. Food and Drug Administration (FDA). Additionally, the Office for Human Research Protections (OHRP) provides ethical standards for protecting participants’ rights and welfare.
Locally, the Arizona Board of Clinical Trials and individual institutional review boards (IRBs) within research institutions play a critical role in reviewing and approving study protocols. These bodies ensure compliance with federal regulations, including informed consent processes, participant confidentiality, and data integrity. Research sites in Phoenix must also adhere to state-specific laws and regulations, which can include additional protections for participants and requirements for reporting adverse events.
Participating in a clinical trial provides a distinctive opportunity to access groundbreaking treatments and therapies before they are released to the general population. Participants benefit from high-quality, personalized care delivered by top healthcare experts who ensure thorough monitoring and customized support throughout the study.
Involvement in clinical trials is crucial for advancing medical research and can lead to significant breakthroughs in the management and prevention of various conditions. By taking part, individuals not only gain early access to innovative medical interventions but also play a pivotal role in advancing scientific knowledge. This contribution helps to shape the future of healthcare, ultimately leading to better outcomes and improved treatment options for future patients.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
Sponsor:
NRG Oncology
Location:
Code:
NCT05896189
Conditions
Breast Cancer
Cognitive Impairments
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Arm 1: Computerized Cognitive Training-Global Stimulation Games
Arm 2: Computerized Cognitive Training-Neuroplasticity Games
Sponsor:
Arizona State University
Location:
Code:
NCT05277389
Conditions
Stroke
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
START - Startle Adjuvant Rehabilitation Therapy
Sham Control
Sponsor:
Philogen S.p.A.
Location:
Code:
NCT03567889
Conditions
Melanoma Stage IIIB/C
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Daromun
Surgery
Adjuvant therapy
Sponsor:
Institute for Molecular Medicine
Location:
Code:
NCT05642429
Conditions
Alzheimer Disease
Eligibility Criteria
Sex: All
Age: 60 - 70+
Healthy Volunteers: Not accepted
Interventions
AV-1959D
Placebo
Sponsor:
Ablacon, Inc.
Location:
Code:
NCT05883631
Conditions
Atrial Fibrillation
Atrial Fibrillation, Persistent
Atrial Fibrillation Paroxysmal
Arrhythmia
Arrhythmias, Cardiac
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
EGF-Mapping and EGF-Guided Ablation of AF Sources
EGF-Mapping of AF Sources (no ablation)
Sponsor:
Stealth BioTherapeutics Inc.
Location:
Code:
NCT06373731
Conditions
Age Related Macular Degeneration (ARMD)
Eligibility Criteria
Sex: All
Age: 55+
Healthy Volunteers: Not accepted
Interventions
Elamipretide
Placebo
Sponsor:
KeraCure
Location:
Code:
NCT00330265
Conditions
Foot Ulcer
Diabetes
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
KC-002
Conventional Wound Therapy
Sponsor:
Medtronic Vascular
Location:
Code:
NCT05198674
Conditions
Hypertension
Vascular Diseases
Cardiovascular Diseases
Chronic Kidney Diseases
Diabetes Mellitus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Renal Denervation (Symplicity Spyral™)
Sponsor:
Abbott Medical Devices
Location:
Code:
NCT03433274
Conditions
Mitral Regurgitation
Mitral Insufficiency
Mitral Valve Insufficiency
Cardiovascular Diseases
Valve Disease, Heart
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tendyne Mitral Valve System
MitraClip System